x
Visit our new Mobile Website next time you access NetDania with your mobile device

SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

21.97
09-19:59:58 GMT
-0.41
-1.83%
ISIN:N/A

Figures - SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

Open
22.65
Close
22.38
Year Change
1.67
Year % Change
+1.67%
52 Week High
25.34
52 Week Low
11.22
Volume
838175
Inc. Vol
142372

News - SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

09-23:03 GMT
Phoenix Suns Fire Head Coach Frank Vogel After One Season
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-23:01 GMT
Korean AI Chip Startup Raises $62 Million Round Led By Ex-Samsung Executive’s Private Equity Firm
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-23:01 GMT
NYT ‘Strands’ #68 Hints, Spangram And Answers For Friday, May 10th
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-23:00 GMT
MultiOn Innovates With Virtual Agents
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:59 GMT
Entrepreneur Arsen Tomsky Talks Being A Stutterer, InDrive, FluentaAI In Interview
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:56 GMT
Netanyahu defiant after US threat to stop weapons
Source: BBC US-Canada, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:52 GMT
Trad Wife Furniture? Stoffer Home And Cloth & Company Launch A Fresh Take On This Trend
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:51 GMT
Where Stormy Daniels' testimony leaves the Trump trial
Source: BBC US-Canada, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:49 GMT
GoodRx (GDRX) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:49 GMT
Medical Properties Trust (MPW) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:44 GMT
Does ‘Kingdom Of The Planet Of The Apes’ Have An End Credits Scene?
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Expensify, Inc. (EXFY) Q1 Earnings and Revenues Miss Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Quest Resource (QRHC) Reports Q1 Loss, Tops Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Trex (TREX) Surpasses Q1 Earnings and Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
HireQuest, Inc. (HQI) Q1 Earnings and Revenues Lag Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Cambium (CMBM) Reports Q1 Loss, Lags Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Haynes International (HAYN) Q2 Earnings and Revenues Lag Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
RB Global (RBA) Q1 Earnings and Revenues Surpass Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Cutera (CUTR) Reports Q1 Loss, Tops Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Array Technologies, Inc. (ARRY) Tops Q1 Earnings Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:39 GMT
Gen Digital (GEN) Tops Q4 Earnings and Revenue Estimates
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:32 GMT
Here’s Taylor Swift’s Updated Eras Tour Setlist In Europe (So Far)
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:28 GMT
The Cursed Class of 2024: To Hire or Avoid?
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:28 GMT
WNBA Will Phase In Charter Flights For The 2024 Regular Season
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:23 GMT
Yeti (YETI) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:23 GMT
Glatfelter (GLT) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:23 GMT
TSX Ends Moderately Higher
Source: NASDAQ US Markets, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:18 GMT
As Europe Deindustrializes, Can Economic Suicide Be Avoided?
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:11 GMT
Top Stocks to Buy After Posting Strong EPS Growth
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:11 GMT
Will the Economy or Recycled Copper Keep a Lid on Copper Prices?
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:11 GMT
Stocks Close Higher on Fed Rate Cut Optimism
Source: NASDAQ Stocks, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:11 GMT
The Netflix Series ‘Bodkin’ Examines The Hard Truth Versus Clouded Memory
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:08 GMT
Bird Flu (H5N1) Explained: 70 People In Colorado Monitored For Illness, Local Officials Say
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-22:06 GMT
Synchronizing IT And Operations Technology (OT): A Framework
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-21:55 GMT
Why Sinclair Stock Was Soaring Today
Source: NASDAQ US Markets, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-21:51 GMT
5 Expert Tips For Pairing Sparkling Wine And Food
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
09-21:43 GMT
How To Repurpose Content For All Your Social Media Platforms
Source: Forbes World, Symbol: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39455.19
26.7
0.07%
5220.89
2.68
0.05%
18139.14
9.51
0.05%
63252.00
1933
3.15%
18748.97
185.22
1.00%
38487.15
37.65
0.10%
3154.32
25.84
0.83%
8426.69
40.58
0.48%
18669.64
314.65
1.71%
7741.73
-52.95
-0.68%
21957.50
-345
-1.55%
2346.81
38
1.65%
84.15
0.415
0.50%
1.07844
0.00378
0.35%
155.347
-0.029
-0.02%
1.25283
0.00354
0.28%
0.66224
0.00449
0.68%
1.36740
-0.0054
-0.39%
167.53300
0.554
0.33%
0.86078
0.00061
0.07%
194.62300
0.514
0.26%
0.90557
-0.0023
-0.25%
0.97662
0.00093
0.10%
0.60381
0.00345
0.57%
105.20100
-0.299
-0.28%
Top Gainers
Name
Last
+/-
%
0.03
0.02
107.78%
3.12
1.42
83.53%
78.59
33.85
75.66%
0.01
0.00
58.54%
0.02
0.01
53.85%
0.28
0.09
47.37%
0.77
0.24
46.39%
0.10
0.03
42.86%
14.16
3.89
37.88%
1.03
0.28
37.44%
Top Losers
Name
Last
+/-
%
0.00
-0.01
-82.22%
1.11
-1.79
-61.72%
0.59
-0.75
-55.97%
2.04
-2.15
-51.31%
0.04
-0.03
-44.79%
0.08
-0.06
-44.06%
4.66
-3.32
-41.60%
0.03
-0.02
-40.92%
7.97
-4.63
-36.75%
9.27
-5.33
-36.51%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy